Literature DB >> 10588385

From neural stem cells to myelinating oligodendrocytes.

B Rogister1, T Ben-Hur, M Dubois-Dalcq.   

Abstract

The potential to generate oligodendrocytes progenitors (OP) from neural stem cells (NSCs) exists throughout the developing CNS. Yet, in the embryonic spinal cord, the oligodendrocyte phenotype is induced by sonic hedgehog in a restricted anterior region. In addition, neuregulins are emerging as potent regulators of early and late OP development. The ability to isolate and grow NSCs as well as glial-restricted progenitors has revealed that FGF2 and thyroid hormone favor an oligodendrocyte fate. Analysis of genetically modified mice showed that PDGF controls the migration and production of oligodendrocytes in vivo. Interplay between mitogens, thyroid hormone, and neurotransmitters may maintain the undifferentiated stage or result in OP growth arrest. Notch signaling by axons inhibits oligodendrocyte differentiation until neuronal signals--linked to electrical activity-trigger initiation of myelination. To repair myelin in adult CNS, multipotential neural precursors, rather than slowly cycling OP, appear the cells of choice to rapidly generate myelin-forming cells.

Entities:  

Mesh:

Year:  1999        PMID: 10588385     DOI: 10.1006/mcne.1999.0790

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  41 in total

1.  The tripotential glial-restricted precursor (GRP) cell and glial development in the spinal cord: generation of bipotential oligodendrocyte-type-2 astrocyte progenitor cells and dorsal-ventral differences in GRP cell function.

Authors:  Ninel Gregori; Christoph Pröschel; Mark Noble; Margot Mayer-Pröschel
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

2.  Multipotent stem cells from the mouse basal forebrain contribute GABAergic neurons and oligodendrocytes to the cerebral cortex during embryogenesis.

Authors:  W He; C Ingraham; L Rising; S Goderie; S Temple
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

3.  Adenosine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials.

Authors:  Beth Stevens; Stefania Porta; Laurel L Haak; Vittorio Gallo; R Douglas Fields
Journal:  Neuron       Date:  2002-12-05       Impact factor: 17.173

Review 4.  DAP12 signaling: from immune cells to bone modeling and brain myelination.

Authors:  Marco Colonna
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

5.  Inhibition of cyclin E-cyclin-dependent kinase 2 complex formation and activity is associated with cell cycle arrest and withdrawal in oligodendrocyte progenitor cells.

Authors:  C Ghiani; V Gallo
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

Review 6.  Cell therapy in demyelinating diseases.

Authors:  Claire Rice; Christopher Halfpenny; Neil Scolding
Journal:  NeuroRx       Date:  2004-10

7.  Assessment of cortical maturation with prenatal MRI. Part I: Normal cortical maturation.

Authors:  Céline Fogliarini; Katia Chaumoitre; Frédérique Chapon; Carla Fernandez; Olivier Lévrier; Dominique Figarella-Branger; Nadine Girard
Journal:  Eur Radiol       Date:  2005-04-23       Impact factor: 5.315

8.  Unliganded thyroid hormone receptor is essential for Xenopus laevis eye development.

Authors:  Emmanuelle Havis; Sébastien Le Mevel; Ghislaine Morvan Dubois; De-Li Shi; Thomas S Scanlan; Barbara A Demeneix; Laurent M Sachs
Journal:  EMBO J       Date:  2006-09-28       Impact factor: 11.598

Review 9.  From stem cells to oligodendrocytes: prospects for brain therapy.

Authors:  Cui P Chen; Mary E Kiel; Dorota Sadowski; Randall D McKinnon
Journal:  Stem Cell Rev       Date:  2007-12       Impact factor: 5.739

Review 10.  Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience.

Authors:  Jerome Mertens; Maria C Marchetto; Cedric Bardy; Fred H Gage
Journal:  Nat Rev Neurosci       Date:  2016-05-19       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.